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Abstract
The POU domain transcription factor Pou3f1 (Oct6/Scip/Tst1) initiates the transition from
ensheathing, promyelinating Schwann cells to myelinating cells. Axonal and other extra-cellular
signals regulate Oct6 expression through the Oct6 Schwann cell enhancer (SCE), which is both
required and sufficient to drive all aspects of Oct6 expression in Schwann cells. Thus, the Oct6
SCE is pivotal in the gene regulatory network that governs the onset of myelin formation in
Schwann cells and provides a link between myelin promoting signalling and activation of a myelin
related transcriptional network. In this study we define the relevant cis-acting elements within the
SCE and identify the transcription factors that mediate Oct6 regulation. On the basis of
phylogenetic comparisons and functional in vivo assays we identify a number of highly conserved
core elements within the mouse SCE. We show that core element 1 is absolutely required for full
enhancer function and that it contains closely-spaced inverted binding sites for Sox proteins. For
the first time in vivo, the dimeric Sox10 binding to this element is shown to be essential for
enhancer activity whereas monomeric Sox10 binding is non-functional. As Oct6 and Sox10
synergize to activate the expression of the major myelin-related transcription factor Krox20, we
propose that Sox10 dependent activation of Oct6 defines a feed-forward regulatory module that
serves to time and amplify the onset of myelination in the peripheral nervous system.
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Introduction
Within the peripheral nervous system (PNS), Schwann cells generate and maintain a multi-
lamellar insulating myelin sheath around an associated axon and impose cellular
specializations that allow fast conduction of action potentials. The generation of myelinating
Schwann cells from an embryonic pool of precursors and the elaboration of the myelin
sheath is primarily controlled by the axons with which the cells associate (Jessen and
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Mirsky, 2005). Axonal signals that include Neuregulin1, Notch1 ligands and neurotrophins,
activate a range of signalling pathways that converge on the nucleus to initiate a program of
myelin-related gene transcription (Svaren and Meijer, 2008; Taveggia et al., 2010).
Several Schwann cell autonomous regulators of myelination have been identified and
studied over the last decades. These include the transcription factors Sox10, NfκB, Notch,
Nfatc4, YY1, Srebp, Oct6, Brn2 and Krox20 (Svaren and Meijer, 2008; Verheijen et al.,
2009; He et al., 2010; Taveggia et al., 2010). Perhaps the most intensely studied are the
POU-domain transcription factor Oct6 (Pou3f1), the Sry-box protein Sox10 and the zinc
finger transcription factor Krox20 (Egr2) (Topilko et al., 1994; Bermingham et al., 1996;
Jaegle et al., 1996; Britsch et al., 2001). Whereas Sox10 is expressed at high levels at all
stages of the Schwann cell lineage, both Oct6 and Krox20 are expressed dynamically in the
Schwann cell lineage during development and nerve regeneration and their expression is
highest in actively meylinating cells (Zorick et al., 1996; Arroyo et al., 1998; Kuhlbrodt et
al., 1998; Finzsch et al., 2010). Genetic studies have shown that deletion of Oct6 and its
close relative Brn2 (also expressed in the Schwann cell lineage with kinetics similar to that
of Oct6), causes severe but transient arrest at the promyelin stage of cell differentiation
resulting in late onset of myelination and hypomyelinated nerves in adult animals
(Bermingham et al., 1996; Jaegle et al., 1996; Jaegle et al., 2003). Deletion of Krox20
similarly results in a differentiation arrest at the promyelin stage but this arrest is
insurmountable (Topilko et al., 1994). Data showing that Oct6/Brn2 cooperate with Sox10
to upregulate Krox20 in myelinating cells through its ‘myelinating Schwann cell element’
(MSE) suggest a model in which Oct6/Brn2 levels serve to time the onset of myelination in
response to promyelinating signals and through activation of Krox20 gene expression
(Ghislain and Charnay, 2006; Svaren and Meijer, 2008; Reiprich et al., 2010). Thus, insight
into how Oct6 itself is regulated is pivotal for our understanding of regulation of
myelination in the PNS.
We have previously shown that a 4,3 kb Schwann cell enhancer (SCE) sequence
approximately 10 kb downstream of the Oct6 transcriptional start site is required and
sufficient to drive temporally correct expression from a linked promoter in Schwann cells
(Mandemakers et al., 2000; Ghazvini et al., 2002). To begin to understand the nature of the
signalling routes that converge on the SCE we set out to identify the functional elements
within the enhancer and identify proteins that bind to these elements.
Materials and Methods
Computational analysis of the Oct6 Schwann cell enhancer
Conserved elements within the Oct6 SCE of human, mouse, rat, opossum, wallaby and
zebrafish were identified using the VISTA phylogenetic alignment tool
(http://pipeline.lbl.gov/cgi-bin/gateway2) (Frazer et al., 2004). All sequences were aligned
to the mouse sequence. The homology cut off standard is 50% but was adjusted to 90% for
the rat sequence because of the close evolutionary relationship between mouse and rat.
Likewise, the homology cut off was adjusted to 30 percent when mouse sequences were
aligned to opossum, wallaby and zebrafish sequences. Alignments were optimized manually.
Aligned sequences were further analyzed for the presence of putative transcription factor
DNA binding sites using ConSite: a web-based tool for finding cis-regulatory elements in
genomic sequences (Sandelin et al., 2004) (http://www.phylofoot.org/consite).
Cell culture, transient transfection and nuclear extract preparation
Primary Rat Schwann cell cultures were established as described previously (Brockes et al.,
1979; Mandemakers et al., 2000). Rat Schwann cells were maintained in Dulbecco’s
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modified Eagle’s medium (DMEM; Lonza), 3% fetal calf serum (FCS; Harlan), 2μM
Forskolin (Sigma), 1% Penicillin and Streptomycin (Invitrogen) and 5% NDF-β conditioned
medium (Spiegel and Peles, 2009) at 37°C with 5% CO2. Schwann cells were differentiated
in vitro towards an early myelinating stage (Morgan et al., 1991), a stage at which they
express relatively high levels of Oct6. First, medium was switched to a serum free
formulation of DMEM/F12 (Lonza), 1X N2 supplement (Invitrogen), 10ng/ml NGF
(Harlan), 0.01%BSA (Invitrogen), 5% NDF-β conditioned medium and 1%PS for 18 hours.
Cells acquire a spindle shaped form under serum free conditions. Then, differentiation was
initiated by addition of 20μM Forskolin (Sigma) or 100 μM CTP-cAMP (Sigma). Cells were
allowed to differentiate for 36 hours before further analysis. Differentiated cells have
flattened cell morphology and express high levels of Oct6.
RT4-D6P2T rat Schwannoma cells (Bansal and Pfeiffer, 1987; Gandelman et al., 1989) were
obtained from ECACC and were maintained in DMEM, 10% FCS and 1% PS. For nuclear
extract preparation RT4-D6P2T cells were grown in 15cm dishes to near confluence. When
confluent, cells were washed once with PBS, scraped in cold PBS and nuclear extracts were
prepared essentially according to Dignam and colleagues (Dignam et al., 1983). Nuclei were
extracted in 20 mM Hepes-KOH pH7.6, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5% NP-40, 0.5 mM DTT and 1 x complete protease inhibitor mix (Roche).
The salt concentration of the extract was reduced by dialysis against a buffer containing 20
mM Hepes-KOH pH7.6, 25% glycerol, 100 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5
mM DTT, 0.2 mM phenylmethylsulfonyl fluoride (PMSF) and 95 μg/ml sodium
metabisulfite. Precipitates were removed by centrifugation two times at 13,000 rpm for 15
minutes, at 4°C. The dialyzed nuclear extract was snap-frozen and stored in aliquots at
−80°C.
HEK293T cells were maintained in DMEM, 10%FCS and 1% PS. HEK293T Cells were
transfected with 20μg pCMV promoter driven full length Sox10 or MIC Sox10 (kind gift
from Prof. Michael Wegner) expression cassettes in 10 cm dishes using the
polyethylenimine (PEI) method. Cells were harvested 48 hours post-transfection for nuclear
extract preparation (Jaegle et al., 2003).
Luciferase assay
Rat Schwann cells were seeded in 6 well Primaria dishes (Becton Dickinson) and grown to
70–80% confluence. Cells were transfected in triplicate with 1.125μg pGL3 luciferase
reporter plasmid (Promega) containing different SCE fragments and 0.375μg pCMV-βgal
reference expression plasmid in the presence of FCS, using FUGENE6 transfection reagent
(Roche) at a 1:4 (DNA:FUGENE6) ratio. Cells were washed 18 hours post transfection, and
medium was switched to a serum free formulation (DMEM/F12 (Lonza), 1X N2 supplement
(Invitrogen), 10ng/ml NGF (Harlan), 0.01%BSA (Invitrogen), 5% NDF-β conditioned
medium and 1%PS). After overnight incubation in this medium, cells were induced to
differentiate through addition of CTP-cAMP to a final concentration of 100μM, and cultured
for an additional 36 hours. Cells were harvested 72 hours post transfection, washed and
lysed in 1X lysis buffer (Promega) and extracts were assayed for luciferase activity using
Steady GLO luciferase substrate buffer (Promega) and β-galactosidase activity using 2-
nitro-phenyl-galacto-pyranoside (ONPG) substrate. Luciferase activities were normalized
for β-galactosidase activity. Both luciferase and β-galactosidase levels were measured on a
luminometer (Perkin Elmer – Victor3). All the experiments were performed at least three
times in triplicate.
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DNA cloning and SCE deletion constructs
The mouse SCE was originally cloned as an HpaI-MscI DNA fragment from a mouse 129sv
cosmid library (Mandemakers et al., 2000). This fragment, which corresponds to position
124,342,041–124,349,427 on mouse chromosome 4 of genome build37 (NCBIM37), was
used to generate, by PCR, a series of 10 deletion constructs in which a shifting window of
approximately 500 basepairs is deleted from the entire SCE. SalI and BglII restriction sites
were introduced at the 5′ and 3′ end respectively and these sites were used to clone the
fragments into the SV40 promotor driven pGL3 luciferase reporter plasmid. Subfragments
from the SCE such as HR1a and HR2 were generated by PCR using the HpaI-MscI SCE
fragment as template and cloned into luciferase and LacZ reporter plasmids (Mandemakers
et al., 2000). Fragment HR1a corresponds to position 124,344,894–124,345,418 and HR2 to
position 124,347,550–124,348,429 on mouse chromosome 4 (NCBIM37).
Transgenic mice and whole mount β-galactosidase staining
Transgenesis and identification of transgenic embryos by PCR and southern blotting was
performed as described previously (Mandemakers et al., 2000). LacZ expression was
visualized by whole-mount X-gal staining of P2-P4 pups or nerves dissected from transgenic
animals at different stages of postnatal development. In brief, young mice (2–4 days of age
and of either sex) were anaesthetized and sacrificed by decapitation. The body cavity was
opened and the major organs were removed. All of the tissue was transferred to a solution of
fixative containing 1% formaldehyde, 0.2% Glutaraldehyde, 2mM MgCl2, 5mM EGTA,
0.02% NP40 in PBS, for 1 hour at room temperature (RT). Tissues were washed in PBS/
0.02% NP40 for 3 times at RT. β-galactosidase staining was carried overnight at RT in
staining solution containing 5mM K3Fe(CN)6, 5mM K4Fe(CN)6.3H20, 2mM MgCl2, 0.01%
Sodium deoxycholate, 0.02% NP40 and 1mg/ml 5-bromo-4-chloro-3-indolyl- beta-D-
galactopyranoside (X-gal). The staining was stopped by extensively washing in PBS/0.02%
NP40 and post fixed in a 4% formaldehyde fixative.
All animal experiments were performed according to guidelines and protocols that had been
approved by an independent committee on the ethical use of experimental animals (DEC).
Electrophoretic mobility shift assay (EMSA)
Equal amounts of nuclear extract were used in the EMSA using 50 fmole of a 32P end-
labeled double-strand oligonucleotide probe. Probe and nuclear extracts were incubated on
ice, for 30 minutes in 10mM HEPES-KOH pH 7.9, 100 mM KCl, 5mM MgCl2, 0.1%
EDTA, 2mM DTT, 4μg BSA and 4% Ficoll in the presence of 2μg of competitor DNA, poly
dG-dC (Sigma). Total reaction volume was 20μl. In super shift experiments, reaction
mixtures were further incubated for 20 minutes with 1μg of Goat-Sox10 antibody
(Santacruz). Complexed and free probe were separated on a 4% polyacrylamide gel which
was pre-run for 30 minutes at 120 volts in 0.5X TBE electrophoresis buffer at RT. Gels were
fixed in 10% methanol/10% acetic acid for 20 minutes, dried and exposed to a Phospho-
imaging screen (Molecular dynamics). ImageJ software was used to analyze the band
intensities. Probes used in the band shift assays are shown in Figure 5.
Chromatin immunoprecipitations
For Chromatin immunoprecipitation (ChIP) assays in RT4D6 cells (20x106 cells/IP), dual
cross-linking was performed using di(N-succimidyl)glutarate (DSG) and formaldehyde (van
den Berg et al., 2008). Cells were washed four times with PBS, followed by incubating the
cells with cross linking agent, 2mM DSG on a rotating platform at a medium speed for 45
minutes at RT. After washing the cells four times with PBS, conventional formaldehyde
cross linking was performed by incubating the cells in freshly prepared buffered
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formaldehyde (50mM Hepes KOH pH 7.5, 100mM Nacl, 1mM EDTA, 0.5mM EGTA, 1%
formaldehyde) for 10 minutes. 2.5M of Glycine was added to a final concentration of
100mM to quench the formaldehyde and cells were further incubated for 5 minutes at RT.
From here on all the subsequent steps were carried at 4°C in the presence of complete
EDTA free protease inhibitor (Roche). Cells were scraped in cold PBS and spun at 2000
rpm for 5 minutes. Cell pellet was resuspended in SDS lysis buffer (1% SDS, 10mM EDTA,
50mM Tris pH 8.0) and subsequently sonicated for 15 cycles with 15-s on and 30-s off
regime. The sheared chromatin was cleared of insoluble debris by centrifugation at 13000
rpm for 10 minutes. The supernatant containing the sheared chromatin was pre-cleared with
protein A Agarose/Salmon sperm DNA (Millipore) for one hour at 4°C. 1% chromatin was
set aside to serve as a 1/100th of total chromatin input control. After centrifugation, the
supernatant was incubated with 10 μg of anti-Sox10 antibody (Abcam) or 10 μg of normal
rabbit immunoglobulin G (IgG; Santa Cruz Biotechnology) control antibody at 4°C on a
rotating wheel overnight. Immune complexes were incubated with 60 μl of protein A
Agarose/Salmon sperm DNA slurry for one hour at 4°C. After centrifugation, the immune
complexes were washed once with 1 ml of low salt buffer (0.1% SDS, 1% Triton X-100,
2mM EDTA, 20mM Tris-Hcl pH 8.0, 150mM NaCl), once with high salt buffer (0.1% SDS,
1% Triton X-100, 2mM EDTA, 20mM Tris-Hcl pH 8.0, 500mM Nacl), once with Lithium
chloride wash buffer (0.25M LiCl, 1% NP-40, 1% deoxycholic acid(sodium salt), 1mM
EDTA, 10mM Tris pH 8.0), and twice with TE buffer (10mM Tris pH8.0, 1mM EDTA) (all
the wash buffers contain protease inhibitor). Immunoprecipitated chromatin was eluted
twice each time with 250 μl of elution buffer (1% SDS, 0.1M NaHCO3). The elutions were
pooled and 5M NaCl was added to a final concentration of 300mM. Further, cross-links
were reversed by incubating the sample at 65°C for 5 hours. The solution was adjusted to
10mM EDTA and 10mM Tris-Hcl pH 6.5. ProteinaseK (10mg/ml) was added to 40μg/ml
and the solution was incubated for one hour at 45°C. DNA was purified with
phenol:chlorform:isoamyl alcohol, precipitated with EtOH and dissolved in water. The same
reverse cross-linking and purification procedure was followed for the input sample.
Comparative Ct values (Livak and Schmittgen, 2001) were used to calculate the enrichment
of a DNA segment relative to the total input. These values were used to calculate the relative
enrichment of Sox10 antibody over rabbit IgG precipitated chromatin for the c1, −13kb and
IgG2a promoter regions. Primer sets used in quantitative PCR for ChIP are as follows: C1 of
SCE: 5′-GCC CTG AGG ACT CTA GCT CT-3′and 5′-GCA GGA CAA TAG CTG CAT
TC-3′, −13kb: 5′-AAT CAC GTC CTC ACC AAA CC-3′ and 5′-TCC GGT TAG CTC
GAA TCC TA-3′, IgG2aP: 5′-GAA ATT CTG CCC TGC ACT TCC-3′ and 5′-GCT TTG
CAT TGA GGG AGG ATC-3′
In vivo formaldehyde assisted identification of regulatory elements (FAIRE)
Freshly isolated P14 rat sciatic nerves were minced in phosphate buffered saline (PBS) with
1% formaldehyde for 5 minute at RT. The nerves were washed with cold PBS and frozen at
−80°C. Following thawing, the nerves were analyzed by Faire as previously described
(Giresi and Lieb, 2009; Jang et al., 2010). A custom microarray (Nimblegen Roche)
consisting of 50kb Oct6 rat gene locus was used for identification of regions enriched by
FAIRE. Labeling of the FAIRE with Cy5 and total input with Cy3 followed by micro-array
hybridization was performed as described (Jang and Svaren, 2009) by Nimblegen. The
enrichment ratio of Cy5 to Cy3 was plotted on a Log2 scale and further processed to display
a moving average using a window size of 5 probes. All raw data sets for the custom tiled
array are available from the NCBI Gene Expression Omnibus website: accession number
GSE23648.
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Results
The Oct6 SCE contains two functionally interdependent conserved modules
Previously, DNaseI hypersensitivity mapping and alignment of the genomes of human,
mouse and rat using the VISTA alignment tool presented here, localized several possible
Oct6 regulatory regions including the SCE (Figure 1A). Among the strongly conserved
regions within the Oct6 locus, only three regions (at −8, −0.5 and +10.5kb) correspond with
previously identified DNaseI hypersensitive sites (HSS: Figure 1A; numbered arrows). The
conserved peak at −4,8kb corresponds with an estradiol responsive enhancer characterized
by Renner and colleagues (Renner et al., 1996). The large conserved region containing the
Oct6 gene contains the promoter proximal region at −0.5kb which confers Interferon-β
responsiveness and is important for the regulated expression of Oct6 in macrophages
(Hofmann et al., 2010). An ultraconserved element flanks the 3′ end of the locus (Figure 1A;
arrowhead) at approximately +15kb (Bejerano et al., 2004) and is downstream of the SCE.
All of these elements are dispensable for Oct6 expression in vivo in the Schwann cell
lineage. The relevance of the other conserved elements, outside the boundaries of the SCE,
for the regulated expression of Oct6 in cells other than Schwann cells is not known.
Within the defined boundaries of the SCE there are two pairs of conserved elements, which
we termed HR1a and HR1b (at +10 to 10.8kb) and HR2a and HR2b (at +13 to13.7kb). The
HR1 region corresponds to DNaseI hypersensitive site 6, whereas HSS7 maps to a
marginally conserved region between HR1 and HR2. To test the relative contributions of
conserved elements within the enhancer to Schwann cell specific expression in transgenic
mice we generated a number of constructs that were linked to the generic minimal promoter
of the Hsp68 gene driving expression of the LacZ gene (Figure 1B). These constructs were
analysed for Schwann cell specific expression of the LacZ reporter in the sciatic nerve of F0
transgenic animals at postnatal day 2 to 4 by whole mount X-gal staining. The blue sciatic
nerve in Figure 1B is a typical example of such analysis. Confirming our previous results
(Mandemakers et al., 2000), the full 4.3 kb SCE construct confers Schwann cell specific
expression in transgenic animals with high frequency (construct 1 Figure 1B; 20 out 26
transgenic animals), whereas the 5′ region (construct 2; 1 out of 7) and 3′ region (construct
3; 0 out of 4) alone did not drive expression in Schwann cells at an appreciable frequency.
However, these constructs abutted in the HSS7 region leaving open the possibility that in
both these constructs essential genetic information was disrupted. To examine this
possibility 5 constructs (construct 4 to 8) spanning the width of the SCE were generated.
Only one (construct 6) of these constructs conferred Schwann cell expression on the hsp68
promoter in transgenic mice although again at a low frequency (1 out of 6 transgenic
animals). We then combined DNA fragments covering HR1 or HR1a and HR2 in one
construct (construct 9 and 10 respectively) and found that both fragments are required to
confer high frequency of reporter gene expression in Schwann cells of transgenic mice.
Furthermore, these data show that HR1 can be reduced to HR1a without loss of activity.
Active enhancer elements are associated with a relatively open chromatin configuration,
devoid of nucleosomes, and these can be probed using FAIRE (formaldehyde assisted
isolation of regulatory elements (Giresi et al., 2007). Using this assay on chromatin derived
from two week old rat sciatic nerve, strong peaks at both HR1a and HR2 were found, in line
with our functional transgenic expression results. Thus, both regions are associated with a
relatively open chromatin structure and are interdependently required for formation of an
active enhancer in Schwann cells.
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Deletion analysis of the SCE in cultured Schwann cells
To more finely delineate the essential elements within the Schwann cell enhancer an in vitro
rat Schwann cell culture system was used, since it is rapid and inexpensive compared to
transgenic mouse experimentation. Primary rat Schwann cells can be cultured indefinitely
(Brockes et al., 1979; Mathon et al., 2001) and, when exposed to agents that elevate
intracellular cAMP levels, can be induced to differentiate into a cell that resembles an early
myelinating Schwann cell. Under these conditions endogenous Oct6 expression is induced
within three hours reaching maximum levels after 24 hours (Monuki et al., 1989). We
generated a series of deletion constructs (Δ1 to Δ10) covering the entire SCE (and cloned
these in a SV40 promoter driven luciferase vector; Figure 2A and 2B). These constructs
were co-transfected with a CMV promoter driven β-galactosidase reference reporter into rat
Schwann cells. Cells were cultured for 18 hours in serum-free medium, switched to
differentiation medium for another 36 hrs and measured for luciferase and β-galactosidase
activity. All luciferase values were normalized for β-galactosidase activity. The activity of
the entire enhancer was set to 100% (Figure 2B) and activity of the various SCE deletions is
reported as percentage of the full SCE activity. From this deletion screen it is evident that a
major enhancing activity is associated with the region covered by Δ3 and, to lesser extent,
Δ2 and Δ10. These regions coincide with the HR1 and HR2 conserved regions.
Next we tested whether the HR1 and HR2 regions, alone or in combination, would enhance
gene expression in transfected Schwann cells (Figure 2B; constructs Δ11, Δ12 and Δ13). In
contrast with our transgenic data, we found that HR1 (Δ12) is as active as the full enhancer
although this activity is further enhanced by the presence of HR2 (as in Δ11). HR2 by itself
is less active than the full enhancer. Further restriction of HR1 to HR1a as in construct Δ14
and Δ15 suggested that the major enhancer activity of HR1 is located within HR1a, but that
this activity is boosted by the presence of HR2 sequences.
To identify the major functional elements within the HR1a region we tested a series of
smaller overlapping fragments HR1a1 through HR1a5 (Figure 2B; constructs Δ16 to Δ21).
Whereas Δ17 and Δ18 gave full enhancer activity as compared to control Δ16 (HR1a), Δ19
further enhanced activity by 5-fold. Constructs Δ20 and Δ21 showed reduced activity.
Interestingly, the HR1a3 sequence associated with very high enhancer activity contains
several consensus binding sites for transcription factors known to be involved in Schwann or
neural crest cell biology (Figure 2C). These include binding sites for Sox, Snail and Creb/
AP-1 proteins, indicating a likely important role for these proteins in mediating the enhancer
effect in differentiating Schwann cells.
A 35 bp core element is essential for Oct6 activation in Schwann cells in vivo
The activity of HR1a3 in combination with HR2 was tested in transgenic mice. Surprisingly,
we found that HR1a3 has no activity in vivo (Figure 3A; construct 12). No Schwann cells
were found to express LacZ in any of the 11 transgenics tested. Moreover, an additional
construct that covers all of HR1a3 and extends to HR2 and 3′ beyond the boundaries of HR2
(construct 11) also did not show activity in vivo. These results are in stark contrast with the
activity of construct 10, which contains 175bp of extra sequence 5′ to HR1a3 (see Figure
1B), and demonstrate that an essential element is missing in constructs 11 and 12.
To identify the missing element(s) we extended our phylogenetic analysis of the SCE to
include the genomes of the Opossum (a non-placental mammal) and the Zebrafish. As is
evident in Figure 3B, homology among the orthologous sequences rapidly breaks down
when more distantly related species are included. Note that the threshold for the genomes of
Opossum and Zebrafish has been lowered to 30%. However, when we manually aligned the
sequences abutted by the 5′ border of construct 10 and 11, one short element of
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approximately 35 basepairs was found strongly conserved in mammals and marsupials
(Figure 3C). We refer to this short conserved element as core 1 or c1.
To test whether this c1 sequence represents an essential element of the SCE, we cloned the
sequence in front of HR1a3 of construct 12 to generate construct 13. Indeed, this construct
drives Schwann cell specific expression of the reporter in 9 out of 18 transgenic mice
(Figure 3A), demonstrating that this short element contains genetic information that is
essential for Schwann cell specific enhancer function in vivo.
Temporal control of gene expression through the SCE is promoter independent
Previously, our experiments showing that the Oct6 SCE drives temporally correct
expression of a reporter gene in the Schwann cell lineage, including its downregulation in
fully differentiated cells, were performed with the Oct6 promoter driving reporter gene
expression (Mandemakers et al., 2000). The use of the Oct6 promoter leaves open the
possibility that the observed down regulation of the reporter gene was mediated through
Oct6 promoter sequences and/or the SCE. Now, to test whether SCE construct 13 contains
all the information to drive regulated expression and does so irrespective of the linked
promoter, transgenic lines (two lines for each construct) were generated in which the LacZ
reporter is driven by the Oct6 promoter or the Hsp68 promoter. We choose one line for each
construct with comparable copy-number for further analysis (Figure 4A). LacZ reporter
gene expression in the sciatic nerve of transgenic mice was monitored at different stages of
development and compared with LacZ expression in nerves of mice carrying a LacZ-neo
fusion (βgeo) gene knocked in the Oct6 locus (Jaegle et al., 1996). As shown in Figure 4B,
SCE construct 13 drives temporal expression from both the Oct6 and Hsp68 promoter in a
pattern that largely follows that of the endogenous Oct6 gene (Oct6βgeo). Both lines show
up-regulation of reporter gene expression at later stages of embryonic development (E16 to
first day of postnatal life) and expression is down-regulated after the first week of postnatal
development and extinguished at later stages. However, expression of Hsp68LacZSCE13 is
initiated slightly ahead of Oct6βgeo, but is extinguished correctly, whereas Oct6LacZSCE13
expression is initiated correctly but is extinguished with slower kinetics. As we analysed
only one line for each construct we do not know whether these marginal deviations in
expression are caused by chromosomal integration position effects or whether they reflect
differences between the Oct6 and Hsp68 promoter. Nevertheless, it is clear that SCE
construct 13 contains all elements to respond to the transcription factor environment of
differentiating Schwann cells and the signalling pathways that regulates their activities and
that no Oct6 promoter specific sequences are required for downregulating Oct6 expression
in mature myelin forming cells.
Core element 1 contains an atypical dimeric binding site for Sox10
How does core element 1 (c1) contribute to Schwann cell specific enhancer function of the
SCE? Using online bioinformatic tools we identified potential binding sites within this 35bp
sequence for several classes of transcription factors including Sox proteins. Sox10, Sox2,
Sox13 and Sox4 (Kuhlbrodt et al., 1998); and data not shown) are expressed in immature
Schwann cells. Whereas all of these proteins bind to the consensus Sox binding site (A/T)
(A/T)CAA(A/T)G, as found in element HR1a3, only Sox10 and Sox13 (not shown) bind to
the c1 element in electrophoretic mobility shift assays (EMSA) (Figure 5A; (Harley et al.,
1994). We examined the formation of protein-DNA complexes on the c1 probe using rat
Schwannoma RT4D6 nuclear extracts and nuclear extracts of HEK293 cells transfected with
a Sox10 expression cassette (Sox10 in Figure 5A). RT4D6 cells resemble an early
myelinating cell as it expresses considerable amounts of Oct6, Krox20, Sox10 and low
amounts of Mpz (Hai et al., 2002; Lindsley et al., 2007); and unpublished observations) and
thus provide an excellent model system to study promyelin-related transcription. Three
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major complexes were observed (indicated with asterisks in Figure 5A) of which the slowest
migrating complex contains Sox10 as evidenced by the further decrease in electrophoretic
mobility of this complex after addition of Sox10 specific antibodies (Figure 5A).
Interestingly, the Sox10 containing complex on the c1 probe has a lower mobility than the
Sox10 complex formed on the c2 probe (Figure 5A) suggesting that Sox10 binds to c1 as a
homo- or heterodimer. The sequence of the c2 probe (Figure 5E) is derived from fragment
HR1a3 and contains a consensus Sox binding site (underlined in Figure 2C). Homodimeric
binding of Sox10 has been described before and depends on the presence of two closely
spaced heptameric Sox binding sites in an inverted orientation (Peirano and Wegner, 2000).
Examination of the c1 sequence revealed the presence of a degenerate Sox binding site
(AACTGAG) in opposite orientation and 4 basepair spacing with the degenerate
CACAAAC Sox binding site (Figure 5E). To confirm that Sox10 binds to c1 as a dimer we
performed EMSA (Figure 5B) with nuclear extracts of HEK293 cells transfected with an
expression construct encoding a truncated form of Sox10 (Sox10 MIC; aminoacid 1–189
including the Sry-box). It has been shown before that this shorter form of Sox10 binds
predominantly as a dimer on closely spaced inverted Sox binding sites such as present in the
Mpz promoter (C/C’ Figure 5E; see (Peirano and Wegner, 2000). Indeed, Sox10MIC binds
as a dimer to c1 and this binding is abolished when the 5′ Sox site is mutated (c1mut). Thus,
the two degenerate Sox binding sites bind Sox10 strongly as a dimer whereas the individual
3′ Sox site has very little affinity for Sox10.
Next we examined whether indeed Sox10 binds to the c1 SCE motif in chromatin of rat
Schwannoma RT4D6 cells. We performed chromatin immune-precipitation assay (CHIP)
using an antibody against Sox10 and control rabbit IgGs. We found c1 SCE sequences
precipitated with three-fold higher efficiency with Sox10 antibodies versus control IgG
antibodies. Two control sequences, a −13kb sequence upstream of Oct6 and the IgG2a
promoter showed no enrichment for Sox10 and were precipitated with equal efficiency by
Sox10 and IgG antibodies (Figure 5C). Thus, Sox10 occupies c1 SCE chromatin in RT4D6
cells.
To test whether this dimeric Sox10 binding contributes to SCE function in vivo we
generated a number of reporter constructs and tested their activity in transgenic animals. All
these constructs are based on construct 12 and include HR1a3 and HR2. First we tested
whether mutation of the 5′ degenerate Sox site had any effect on the contribution of c1 to
SCE activity. Mutating 5 nucleotides, including the particularly important central CAA
motif, as in c1mut (Figure 5E) results in loss of Sox10 binding (Figure 5B). Replacing the c1
sequence in construct 13 for the c1mut sequence, to generate construct 14, results in a strong
reduction of the number of transgenic mice expressing the LacZ reporter in Schwann cells of
the sciatic nerve, from 9 out of 18 to 1 out of 9 (Figure 5D). Thus, Sox10 binding to c1 is an
essential component of the fully active SCE.
As c1mut completely abolishes Sox10 binding we could not determine whether dimeric
Sox10 binding per se, or perhaps monomeric Sox10 binding, would suffice for SCE
function. To answer these questions we tested two additional constructs. In the first
construct tested, construct 15, we replaced the c1 sequence with that of the well documented
C/C’ dimeric Sox10 binding site from the Mpz promoter (Peirano and Wegner, 2000). In the
second construct tested, construct 16, we replaced the c1 sequence for the C/C’ derivative C,
to which Sox10 binds exclusively as a monomer (sequence is shown in Figure 5E). As is
evident from the numbers presented in Figure 5D, the Mpz promoter derived C/C’ Sox
binding site is as effective as the original c1 sequence in supporting Schwann cell specific
expression (construct 15; 7 out of 10). However, the monomeric Sox site C is not an
effective substitute for c1 (Figure 5D construct 16; 1 out of 6). Thus, these experiments
show that it is dimeric binding of Sox10 to the c1 sequence and not just Sox10 binding per
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se that provides an essential function in Schwann cell specific regulation through the Oct6
SCE.
Discussion
We have combined comparative genomics and transgenic analysis to identify regulatory
regions within the Oct6 SCE that are required to drive Schwann cell specific expression in
transgenic mice. We demonstrate that a 35 bp fragment called c1 is an essential element of
the SCE and contains two degenerate Sox protein binding sites in an inverted orientation.
Sox10 protein binds to this element as a dimer and we demonstrate that its in vivo activity
critically depends on dimeric binding of Sox10, as enhancer activity is lost in DNA mutants
that bind Sox10 as a monomer. Thus, dimeric Sox10 binding provides a crucial function
within the larger context of the Oct6 SCE including HR1a and HR2, allowing the formation
of a productive enhanceosome in response to developmental cues.
Phylogenetic comparison of genome sequences is a powerful tool to identify putative gene
regulatory sequences. We initially analyzed human, mouse and rat sequences of
approximately 50kb surrounding the Oct6 gene and identified several conserved DNA
elements surrounding the Oct6 structural gene (Figure 1A). Within the boundaries of the
SCE two pairs of highly conserved blocks could be identified. Inclusion of non-placental
mammals and fish in our analysis however shows that the high degree of homology is lost
over larger evolutionary distances (Figure 3). This rapid decline in overall sequence
conservation down the phylogenetic ladder is remarkable and suggests that the core
elements of the enhancer are relatively insensitive to the composition and sequence of the
DNA in which they are embedded. In line with this observation we found that the 35bp c1
could be lifted from its natural sequence context and placed directly in front of HR1a3 and
HR2 to generate a functional enhancer (Figure 3A).
HSS1 is associated with the promoter region of Oct6 and is embedded in a CpG island.
Promoter proximal elements mediate interferon and dsRNA responses in fibroblasts,
macrophages and possibly Schwann cells through binding of the transcription factor Stat1
(Hofmann et al., 2010). These elements fall within the limits of HSS1. Our analysis of
transgenic founder animals carrying different SCE constructs did not reveal a role for
promoter proximal sequences in directing Schwann cell specific expression. However, it did
not rule out a possible contribution of these sequences to the temporal control of Oct6 gene
expression, in particular down-regulation in fully myelinating cells. Oct6 down-regulation in
myelinating Schwann cells is important as forced expression of Oct6 beyond the initial
stages of myelination results in myelin degeneration and neuropathy (Ryu et al., 2007). It
has been suggested that Oct6 gene expression is extinguished through an auto-inhibitory
mechanism and/or through the action of Krox20 (see Figure 6) possibly through binding to
the many potential Krox20 binding sites in the Oct6 promoter (Jaegle and Meijer, 1998;
Zorick et al., 1999; Svaren and Meijer, 2008). Our results with SCE13 containing constructs,
shown in Figure 4, demonstrate that the Oct6 promoter can be replaced by the minimal
Hsp68 promoter. The downregulation of these constructs in mature nerves suggests that
downregulation is mediated through the SCE and does not depend on Oct6 promoter specific
sequences. Whether Oct6 down-regulation involves active repression by Krox20 or other
factors, or loss of activation is an open question. Further insight into the developmental
down-regulation of Oct6 will depend on the future identification of the relevant sequences
within the SCE.
Our detailed mapping of HR1a using a transient reporter Luciferase assay defines a 177bp
fragment HR1a3 that is highly active in differentiating rat Schwann cells. This element
contains binding sites for a number of transcription factors that are expressed in Schwann
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cells including Sox, Snail, cAMP-response-element-binding (CREB) and fos/jun proteins
(Figure 2). Of particular interest here is the CRE/AP1 binding site TGCGTCA which has
been shown to mediate cAMP induced expression of dopamine β-hydroxylase (Swanson et
al., 1998). Increased intracellular cAMP concentrations activate PKA which in turn can
activate a variety of proteins including CRE-binding protein (CREB) and the p65 subunit of
NfκB (Tabernero et al., 1998; Yoon et al., 2008). A role for cAMP/PKA in Oct6 expression
in Schwann cells was long suspected but compelling evidence for such a role was obtained
only recently. It was shown by Monk and colleagues that activation of Oct6 in zebrafish
Schwann cells depends on the G-protein coupled receptor Gpr126, a receptor hypothesized
to signal through adenylyl cyclase (Monk et al., 2009). Indeed, pharmacological activation
of adenylyl cyclase in Gpr126 mutant fish larvae activated Oct6 expression in Schwann cells
and rescued the myelination defect in these mutant animals. Phosphorylation of CREB was
also shown to result from Nrg1 signalling through the ErbB2 and ErbB3 heterodimeric
receptor type tyrosine kinases, suggesting that both Gpr126 and ErbB2/ErbB3 signals
contribute to regulated Oct6 gene transcription (see Figure 6) possibly through the CRE/AP1
element present in HR1a3.
However, whereas Luciferase reporter constructs carrying the HR1a3 and HR2 fragment
were highly active in transient transfected rat Schwann cells, a LacZ reporter construct
carrying the same enhancer fragments was inactive in transgenic mice (Figures 2 and 3).
This discrepancy could reflect differences in Oct6 regulation in Schwann cells of different
species. Indeed, it has recently been shown that mouse and rat Schwann cells exhibit
different sensitivities to differentiation cues in vitro (Arthur-Farraj et al., 2011).
Alternatively, the observed discrepancy reflects the fundamentally different nature of the
two assays employed here. In transfection assays, the DNA construct remains episomal,
doesn’t incorporate epigenetic marks and is relatively open to the transcription factor
environment of the nucleus. In contrast, a transgenic reporter construct is integrated in the
chromosome, acquires epigenetic marks and is subject to chromosomal position effects.
Clearly, inclusion of the conserved 35bp fragment c1 (Figure 3 and 4) containing two
inversely oriented heptameric Sox10 binding site restored in vivo enhancer activity to the
HR1a3 and HR2 DNA fragment and thus provides information that allows productive
enhancer function in a chromatin context. Interestingly, two monomeric Sox10 sites as in
construct 16 (C and the c2 sequence embedded in HR1a3; Figure 5D and E) are no
substitute for these inversely oriented sequences in c1 to which Sox10 binds as a dimer.
Sequence dependent dimerization is a property shared by all group E Sox proteins and
depends on a short peptide sequence in the aminoterminal portion of the proteins (Peirano
and Wegner, 2000). The relevance of dimeric SoxE binding first became apparent when it
was found that mutations in Sox9 that abolish dimeric binding but not monomeric binding,
cause a form of Campomelic dysplasia in humans (Sock et al., 2003). Likewise, mutation of
the homologous sequence in mouse Sox10 (Sox10aa1/aa1) results in loss of dimeric DNA
binding, causing specific defects in neural crest derived cell lineages. These include
Schwann cells which are normally generated but fail to enter the promyelinating phase of
differentiation and fail to activate Oct6 expression (Schlierf et al., 2002; Schreiner et al.,
2007). Our demonstration here that the c1 element is a target for dimeric sox10 binding and
is essential for Oct6 activation provides a clear explanation for that observation.
How could dimeric Sox10 binding contribute to regulated expression of Oct6? A dimeric
Sox10 protein binds DNA with higher affinity and induces stronger bending of the DNA
helix than a monomeric Sox10 protein (Peirano and Wegner, 2000). Productive enhancer
formation by dimeric Sox10 could result from the higher DNA binding affinity or,
alternatively, DNA tethered Sox10 dimers assemble protein complexes different from those
assembled by Sox10 on monomeric sites. It is in principle possible that the differences in
DNA topology induced by monomeric and dimeric Sox binding contribute to the latter. It is
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of note that in Sox10aa1/aa1 mice Schwann cells are generated in normal numbers whereas in
the Sox10 null mice Schwann cells are not generated at all (Britsch et al., 2001; Schreiner et
al., 2007). As Sox10aa1 proteins can still bind as a monomer to Sox binding sites, this
suggests that activity of a subset of Sox10 target genes in the Schwann cell lineage depends
on monomeric Sox10 binding, whereas another subset of genes including Oct6 depends on
dimeric Sox10 binding. Furthermore, our transgenic data suggest that dimeric Sox10 creates
an open chromatin configuration in Schwann cells, allowing productive interactions of
transcription factors with the Oct6 SCE. Irrespective of whether this results from qualitative
or quantitative differences between the two modes of Sox10 binding, the functional
implications are profound.
As Sox10 is expressed at high levels at all stages of Schwann cell differentiation, the
dependency of the Oct6 SCE on Sox10 does not provide a ready explanation for the
dynamic expression of Oct6 during Schwann cell differentiation. Most likely this
information is encoded in HR1a3 or HR2. However, we cannot rule out the possibility that
the activity of Sox10 on the Oct6 SCE is regulated through modifications such as
sumoylation (Taylor and Labonne, 2005; Girard and Goossens, 2006). Indeed, it has been
shown that sumoylation of Sox10 represses its capacity to activate specific promoters such
as those of the Mitf and Gjb genes (Girard and Goossens, 2006).
It is expected that future identification of additional transcription factors interacting with
regulatory elements within HR1a3 and HR2 will provide further insight into the temporal
regulation of Oct6 gene expression and myelin related gene expression.
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Figure 1. Comparative genomic and functional analysis of the mouse Oct6 locus
(A) Vista alignment of the mouse, rat and human Oct6 locus spanning approximately 50kb.
The position of the Oct6 transcription unit and the SCE are indicated above the plot. The
Oct6 open reading frame is in red with the POU domain in dark blue and the 3′ untranslated
region in light blue. The grey arrowhead marks the position of the ultra-conserved sequence
and numbered arrows the position of the previously mapped DNaseI hypersensitive sites
(Mandemakers et al., 2000). Repeat sequences present in the mouse genome are indicated.
Note that the homology threshold has been adjusted to 90% for the rat sequence.
(B) The enlarged section of the SCE region shows the four regions of strong homology
HR1a and b and HR2a and b between mouse and human sequences. The approximate
position of HSS6 and 7 as well as the short repeat sequences (in green) are indicated. The
black lines represent the segments of the SCE that were cloned behind the hsp68LacZ
reporter construct. Individual constructs were tested for activity in transgenic mice and the
number of transgenic founders (nr of tg) and those that express the hsp68LacZ in the
peripheral nerves (nr LacZ+) are indicated. A dissected sciatic nerve of a P2 mouse
transgenic for construct 9 is shown as a typical example. (C) The FAIRE plot of the rat Oct6
SCE is shown at the same scale as the Vista plot in B to allow a direct visual comparison of
the two plots. The coordinates of the rat genome sequence (RN4) are indicated. The red bar
indicates sequences not represented on the custom made micro array used in this
experiment.
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Figure 2. Dissection of Oct6 SCE functional elements in differentiating Schwann cell cultures
(A) SCE constructs were cloned behind the minimal SV40 promoter-driven Luciferase
cassette (pGL3) and transfected in rat Schwann cells. (B) The SCE constructs tested are
represented with a black line and aligned with the Vista plot. Luciferase activity of each
construct is expressed as a percentage of the activity of the full SCE in these experiments.
All transfections were performed in triplicate. (C) The sequence of HR1a3, which has strong
enhancer activity in the luciferase assay, shows potential binding sites for transcription
factors known to be involved in Schwann cell biology. These potential binding sequences
were identified using the phylogenetic footprinting program ConSite. The sequence of the c2
element, containing the consensus Sox binding site, is underlined.
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Figure 3. Functional analysis of SCE elements in transgenic mice and comparative genomics
(A) Schematic depiction of the SCE constructs tested in transgenic mice. The SCE
constructs are represented by black lines aligned with the Vista plot of the mouse SCE to
visualize the presence or absence of conserved sequences in the various constructs. The total
number of transgenic animals (nr of tg) and the number of animals that express the transgene
in neonatal peripheral nerves (nr LacZ+) is indicated. All animals were analysed as founders.
(B) Vista alignment of human SCE sequence with mouse, dog (Canis familiaris), opossum
(Monodelphis domestica) and zebrafish (Danio rerio). Note that the lower homology
threshold has been set to 30% for opossum and zebrafish to allow for the visualization of
more diverged homologous regions. The position of core element c1 in the Vista plot of
opossum is indicated by an arrow. (C) Alignment of core element c1 in the SCE of human,
mouse, opossum and wallaby (Macropus eugenii). Hundred percent homologous nucleotides
are boxed in black, 75% homology in light blue and 50% homology in ochre.
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Figure 4. Developmental control of Schwann cell specific expression through SCE13
(A) Southern blot of genomic DNA of the two transgenic lines analysed here shows that
they carry a comparable number of transgenes. The transgene is detected with a LacZ probe
that hybridizes to a 3.5kb BamHI restriction fragment derived from the transgenic construct.
The Oct6 locus is detected with a probe that hybridizes with two fragments of 2.8 and 2.4kb
in length. The equal intensity of these endogenous band shows that equal amounts of DNA
were loaded in both lanes. (B) Transgenic animals carrying a LacZ reporter gene driven by
either the Oct6 promoter or the Hsp68 promoter and controlled by SCE construct 13,
Oct6LacZSCE13 and Hsp68LacZSCE13 respectively, were stained for β-galactosidase
activity in Schwann cells of the sciatic nerve at different stages of pre- and postnatal
development. Developmental expression of β-galactosidase activity in nerves of the two
transgenic lines was compared to the β-galactosidase activity in Oct6 β-galactosidase-
neomycin (Oct6-βgeo) heterozygous knock in animals (Jaegle et al., 1996; Mandemakers et
al., 2000).
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Figure 5. Biochemical and functional analysis of core element c1
(A) EMSA with radiolabelled doublestranded oligonucleotides c1 and c2. The sequence of
these probes is depicted in panel E. Oligonucleotide probes were incubated with nuclear
extracts from RT4D6 cells or from HEK293 cells over-expressing Sox10 (labelled Sox10),
in the presence (+) or absence (-) of Sox10 antibodies, as indicated. The three major DNA-
protein complexes formed on c1 with RT4D6 nuclear proteins are marked with an asterisk.
The Sox10 monomeric and dimeric complexes are indicated with arrows. (B) EMSA with
radiolabelled doublestranded oligonucleotide c1 and c1mut. Oligonucleotide probes were
incubated with increasing amounts of nuclear extracts from HEK293 cells expressing Sox10
MIC. (C) ChIP of Oct6 SCE sequences using Sox10 antibodies. Chromatin of RT4D6 cells
was precipitated with Sox10 or rabbit IgG antibodies. The non-specific rabbit IgG antibodies
served as a control. Quantitative PCR on immune-precipitated and purified DNA using
primers for the c1 region (c1), a region 13kb upstream of the Oct6 promoter (−13kb) and a
region associated with the IgG2a promoter (IgG2aP) was performed in triplo and was used
to determine the relative enrichment for these loci by Sox10 over IgG immune-precipitation.
The experiment was performed twice. Data from both experiments are presented (1 and 2).
(D) Functional analysis of Sox binding sites in element c1. The in vivo activity of the
various SCE constructs was assessed in new born founder animals. The number of
transgenic animals (nr of tg) and the number of animals that express LacZ in the peripheral
nerves (nr LacZ+) is indicated. Constructs 14, 15 and 16 were created from construct 13 by
replacing the c1 sequence for that of c1mut, C/C’, and C respectively. (E) Sequence of c1
and related elements and its various mutant derivatives. Red asterisks indicate the
nucleotides mutated in c1mut. The position and orientation of the Sox10 binding sites is
indicated by green boxes and arrows. The C/C’ and C sequence is derived from the Mpz
promoter (Peirano et al., 2000). Differences between C/C’ and C are indicated with red
asterisks. The consensus Sox DNA binding motif was derived by Harley and colleagues
(Harley et al., 1994)
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Figure 6.
The figure provides a schematic representation of the gene regulatory network that governs
the transition from a premyelinating Schwann cell to a myelinating cell and incorporates
findings described in this study. Different signalling pathways converge on the regulatory
elements in this network and cooperate with Sox10 to control Oct6, Krox20 and myelin gene
expression (Svaren and Meijer, 2008). The Sox10 dependent activation of Oct6 and
subsequent synergistic activation of Krox20 defines a feed-forward (FF) regulatory module.
Sox10 then cooperates with Krox20 to control expression of myelin related genes, through
closely spaced Krox/Sox (K/S) binding elements, defining a second feed-forward loop.
These FF loops serve to time and amplify the onset of myelination in the PNS. For further
details see text.
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